Orion Oyj (ORNBV.HE)
18.60EUR
18 Jun 2013
€-0.13 (-0.69%)
€18.73
€18.72
€18.75
€18.47
330,756
329,401
€24.58
€13.99
ORNBV.HE
About
Overall
| Beta: | 0.27 |
| Market Cap (Mil.): | €2,641.53 |
| Shares Outstanding (Mil.): | 141.26 |
| Dividend: | 1.30 |
| Yield (%): | 6.94 |
Financials
| ORNBV.HE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 12.98 | 31.05 | 31.28 |
| EPS (TTM): | 1.44 | -- | -- |
| ROI: | 39.04 | 19.56 | 18.90 |
| ROE: | 56.23 | 20.32 | 19.80 |
UPDATE 1-NORDIC STOCKS - Factors to watch on June 3
HELSINKI, June 3 - The following stocks may be affected by newspaper reports and other factors on Monday:
BRIEF-Orion Diagnostica to cut 80 jobs in Finland
HELSINKI, June 3 - Orion Oyj : * Orion Diagnostica's statutory co-operation negotiations completed * Says 60 persons of the company's personnel in Finland will be given a notice * Says in addition about 20 people will leave their positions due to a
BRIEF-Orion to issue a bond
HELSINKI, May 20 - Orion Oyj : * Orion Corporation is preparing to issue a bond * says is preparing to issue a EUR 100-150 million senior, unsecured bond that would mature in 5-7 years (Reporting by Helsinki Newsroom)
UPDATE 1-Orion profit falls on generic competition
* Generic competition increasing as patents expire (Adds bullets, company statement)
Orion profit falls as Parkinson's drug patents expire
HELSINKI, April 23 - Finnish drug maker Orion reported a fall in first-quarter profit, in line with expectations, due to the expiration of its patents for Parkinson's drugs.
UPDATE 1-NORDIC STOCKS - Factors to watch on April 10
HELSINKI, April 10 - The following stocks may be affected by newspaper reports and other factors on Wednesday:
BRIEF-Orion plans to cut 80 jobs in Finland
HELSINKI, April 10 - Orion Oyj : * Orion Diagnostica proposes co-operation negotiations on streamlining its
BRIEF-Orion applies to market asthma products in Europe
HELSINKI, March 21 - Orion Oyj : * Submitted a marketing authorisation application for Easyhaler asthma products
Richter signs development deal with Finland's Orion
BUDAPEST, March 12 - Hungary's leading drug producer Richter has signed a long-term research and development cooperation agreement with Finnish pharmaceuticals company Orion Corporation, Richter said in a statement on Tuesday.
UPDATE 1-Orion says new products to soften generics blow
HELSINKI, Feb 5 - Finnish drug maker Orion said sales of new products were helping to soften the blow of increasing generic competition for its Parkinson's drugs, forecasting stronger-than-expected sales for 2013.
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Thomson Reuters StreetEvents
|
$75.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
